Nucleai AI tissue analytics for ADC clinical programs
Disclosed: Verified: Partners: Nucleai
Nucleai says it has used AI to analyze H&E and IHC whole-slide images from several Gilead oncology clinical studies in support of Gilead's ADC clinical programs, generating candidate spatial biomarkers.